In addition to the metabolic derangement precipitated by obesity, cannabinoids activate CB1 receptors in peripheral tissues causing lipogenesis, reduced insulin responsiveness and impaired secretion of insulin in adipose tissues, liver, skeletal muscles and pancreas [10]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.